Soft Tissue Sarcoma

Soft Tissue Sarcoma is the indication for 7 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as: Sarcoma, Soft Tissue · Soft Tissue Sarcomas · Soft-Tissue Sarcoma · Malignant Mesenchymal Tumor · Sarcoma, Soft-tissue
Classified under: Musculoskeletal and Connective Tissue Diseases
Neoplasms
Indicated drugs: Docetaxel
Epirubicin
Ifosfamide
Methotrexate
Olaratumab
Temozolomide
Vinorelbine

Resolves to

Vocabularies

MeSHM0530161SNOMED CT1187396000MedDRA10025673UMLSC0334492

What you can answer from here — as of September 26, 2026

7Indicated drugsWith each drug's targets and mechanism

Listed above

7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

516Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Soft Tissue Sarcoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.